Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

LANHAM RANDALL J — NYMOX PHARMACEUTICAL CORP insider: 1 transactions · InsiderLens

Home / Insiders / LANHAM RANDALL J

LANHAM RANDALL J

Director at NYMOX PHARMACEUTICAL CORP · on record since Nov 6, 2018
General Counsel at NYMOX PHARMACEUTICAL CORP · on record since Nov 6, 2018

Insider trading activity of LANHAM RANDALL J

Transactions on record: 1; since Nov 6, 2018

Open-market buys: 1; $5K

Open-market sells: 0

Companies traded: 1; last filing Nov 6, 2018

Figures computed from official regulatory filings — methodology.

Companies where LANHAM RANDALL J has traded

NYMOX PHARMACEUTICAL CORP1 tx · $5K · Nov 6, 2018

Track record of LANHAM RANDALL J

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of LANHAM RANDALL J

Co-insiders of LANHAM RANDALL J

Averback PaulNYMOX PHARMACEUTICAL CORP
Danielsen ErikNYMOX PHARMACEUTICAL CORP
Robinson James GeorgeNYMOX PHARMACEUTICAL CORP

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
NYMOX PHARMACEUTICAL CORP	Nov 6, 2018	Buy	2,900	1.72 USD	$5K	SEC